Homeostasis of the gut microbiota critically influences host health and aging. Developing genetically engineered probiotics holds great promise as a new therapeutic paradigm to promote healthy aging. Here, through screening 3,983 Escherichia coli mutants, we discovered that 29 bacterial genes, when deleted, increase longevity in the host Caenorhabditis elegans.
More informationRecent Posts
- The oesophageal microbiome and cancer: hope or hype?
- Altering the microbiome for immunotherapy-resistant urological tumors-An intriguing but still early concept
- Fecal microbiota transplantation for immunotherapy-resistant urological tumors: Is it time? An update of the recent literature
- 7th International Congress on Probiotics, Prebiotics in Pediatrics
- Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study